YKL-5-124 is a covalent, highly selective CDK7 inhibitor with an IC50 of 9.7 nM against the CDK7/Mat1/CycH complex, demonstrating over 130-fold selectivity versus CDK2 and CDK9. It is a valuable chemical probe for studying transcriptional regulation and cell cycle progression in cancer research models, both in vitro and in vivo.